SPOTLIGHT -
Dr. Kansagra on Updates With CAR T-Cell Therapy in Hematologic Cancers
Ankit Kansagra, MD, discusses key updates with CAR T-cell therapy in hematologic cancers.
Read More
Dr. Kansagra on Updates With CAR T-cell Therapy in Myeloma
Ankit Kansagra, MD, discusses updates with CAR T-cell therapy in multiple myeloma.
Dr. Kansagra on Remaining Questions With CAR T-Cell Therapy in Multiple Myeloma
Ankit Kansagra, MD, discusses remaining questions with CAR T-cell therapy in multiple myeloma.
Dr. Kansagra on Expanding Role of CAR T-Cell Therapy in Lymphoma and Multiple Myeloma
Ankit Kansagra, MD, discusses the expanding role of CAR T-cell therapy in lymphoma and multiple myeloma.
Dr Hamilton on the Efficacy and Safety of Abemaciclib Plus ET in Elderly Patients With HR+/HER2- Breast Cancer
Acalabrutinib and Zanubrutinib Produce Similar PFS in a Matching-Adjusted Indirect Comparison in R/R CLL
Nivolumab Plus Relatlimab Demonstrates Consistent Benefit for Patients with Advanced Melanoma
Dr Rini on Sustained Survival Outcomes After Completion of Pembrolizumab and Axitinib in ccRCC
